Giuseppe Michieli<p><a href="https://mstdn.science/tags/Structural" class="mention hashtag" rel="tag">#<span>Structural</span></a> and <a href="https://mstdn.science/tags/virologic" class="mention hashtag" rel="tag">#<span>virologic</span></a> <a href="https://mstdn.science/tags/mechanism" class="mention hashtag" rel="tag">#<span>mechanism</span></a> of the emergence of <a href="https://mstdn.science/tags/resistance" class="mention hashtag" rel="tag">#<span>resistance</span></a> to <a href="https://mstdn.science/tags/Mpro" class="mention hashtag" rel="tag">#<span>Mpro</span></a> <a href="https://mstdn.science/tags/inhibitors" class="mention hashtag" rel="tag">#<span>inhibitors</span></a> in <a href="https://mstdn.science/tags/SARS" class="mention hashtag" rel="tag">#<span>SARS</span></a>-CoV-2, PNAS: <a href="https://www.pnas.org/doi/abs/10.1073/pnas.2404175121?af=R" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://www.</span><span class="ellipsis">pnas.org/doi/abs/10.1073/pnas.</span><span class="invisible">2404175121?af=R</span></a> </p><p>We generated SARS-CoV-2 variants resistant to three SARS-CoV-2 main protease (Mpro) inhibitors (<a href="https://mstdn.science/tags/nirmatrelvir" class="mention hashtag" rel="tag">#<span>nirmatrelvir</span></a>, TKB245, and 5h), by propagating the ancestral SARS-CoV-2WK521WT in VeroE6TMPRSS2 cells with increasing concentrations of each inhibitor and examined their structural and virologic profiles.</p>